Loss of performance of antibiotic therapies potential clients towards the urgent have to develop alternate control agents, such as for example monoclonal antibodies (MAbs) (47)
Loss of performance of antibiotic therapies potential clients towards the urgent have to develop alternate control agents, such as for example monoclonal antibodies…